Chloroprocaine for Continuous Epidural Analgesia in Neonates and Infants

This a study to retrospectively review our experience with the use of chloroprocaine for postoperative epidural infusions in neonates and infants. Pain scores and the need for intravenous analgesic agents will be recorded from the records to demonstrate the efficacy of the technique.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Anesthesia

Age range

Up to 2 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Nationwide Children's Hospital

Columbus, Ohio, 43205, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Neonates and infants who have received chloroprocaine for epidural anesthesia.

Exclusion criteria

None

Treatment and study plan

Chloroprocaine

Drug

Primary outcomes

Pain score

Time frame: Every 6 hours for 72 hours

Secondary outcomes

Pain medicine consumption

Time frame: Every 6 hours for 72 hours

Sponsors and collaborators

Lead sponsor

Joseph D. Tobias

Other

Registry information

Important dates

Study start: 2014
Primary completion: 2015
Study completion: 2015
First posted: Aug 4, 2014
Registry last updated: Nov 29, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed